SPDR S&P Biotech ETF (XBI) -1.5%
Biotech stocks are settling following Monday's rally. As a result, ETFs including XBI and the First Trust Amex Biotechnology Index Fund (FBT) are witnessing losses.
Dendreon (DNDN), the closely watched name that saw staggering gains at the start of the week, is giving back some of its winnings, dipping 2.6%.
All prices as of 2:13 PM ESTWritten by Don Dion in Williamstown, Mass.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts